Complementary targeted constructs factor XI/XIa inhibition
Richard C Becker · 2026
Read Complementary targeted constructs factor XI/XIa inhibition by Richard C Becker (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13528377.txt.
Description
Richard Becker wrote in 2026 about bringing precision medicine to blood clot treatment, through drugs that block clotting factor XI. Oncology got closest to the precision ideal by redefining cancers as molecular diseases and matching drugs to them. That success rests on deep tissue profiling, patient layering by biology, and disease labels that evolve with knowledge. Becker asks whether clotting care can reach the same resolution.
Clots are harder: they are shifting states, not fixed diseases, shaped by vessels, cells, proteins, flow, and inflammation, and they can change within hours. Platelet reactivity and clotting factor levels swing with illness, surgery, or drugs. Today's therapies are therefore one-size-fits-most. Targeted factor XI constructs may open a finer path, the letter argues.
Catalog record
| CREATOR | Richard C Becker |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |